Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin and Interpersonal Psychotherapy for Major Depressive Disorder
NCT02405715Phase 2Completed
- Sponsor
- Concordia University
- Start
- Feb 2015
- Primary completion
- Aug 2016
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in major depressive disorder (MDD), sponsored by Concordia University. Started Feb 2015; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02405715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02405715.